GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » The Jean Coutu Group (PJC) Inc (OTCPK:JCOUF) » Definitions » 1-Year ROIIC %

The Jean Coutu Group (PJC) (The Jean Coutu Group (PJC)) 1-Year ROIIC % : 0.00% (As of Nov. 2017)


View and export this data going back to . Start your Free Trial

What is The Jean Coutu Group (PJC) 1-Year ROIIC %?

1-Year Return on Invested Incremental Capital (1-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 1-year. The Jean Coutu Group (PJC)'s 1-Year ROIIC % for the quarter that ended in Nov. 2017 was 0.00%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for The Jean Coutu Group (PJC)'s 1-Year ROIIC % or its related term are showing as below:

JCOUF's 1-Year ROIIC % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 1.545
* Ranked among companies with meaningful 1-Year ROIIC % only.

The Jean Coutu Group (PJC) 1-Year ROIIC % Historical Data

The historical data trend for The Jean Coutu Group (PJC)'s 1-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The Jean Coutu Group (PJC) 1-Year ROIIC % Chart

The Jean Coutu Group (PJC) Annual Data
Trend May07 Feb09 Feb10 Feb11 Feb12 Feb13 Feb14 Feb15 Feb16 Feb17
1-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

The Jean Coutu Group (PJC) Quarterly Data
Feb13 May13 Aug13 Nov13 Feb14 May14 Aug14 Nov14 Feb15 May15 Aug15 Nov15 Feb16 May16 Aug16 Nov16 Feb17 May17 Aug17 Nov17
1-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of The Jean Coutu Group (PJC)'s 1-Year ROIIC %

For the Pharmaceutical Retailers subindustry, The Jean Coutu Group (PJC)'s 1-Year ROIIC %, along with its competitors' market caps and 1-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


The Jean Coutu Group (PJC)'s 1-Year ROIIC % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, The Jean Coutu Group (PJC)'s 1-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where The Jean Coutu Group (PJC)'s 1-Year ROIIC % falls into.



The Jean Coutu Group (PJC) 1-Year ROIIC % Calculation

The Jean Coutu Group (PJC)'s 1-Year ROIIC % for the quarter that ended in Nov. 2017 is calculated as:

1-Year ROIIC %=1-Year Incremental Net Operating Profit After Taxes (NOPAT)**/1-Year Incremental Invested Capital
=( 138.6495 (Nov. 2017) - 151.8655 (Nov. 2016) )/( 821.263 (Nov. 2017) - 786.884 (Nov. 2016) )
=-13.216/34.379
=-38.44%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** TTM data of NOPAT and Invested Capital was used to calculate 1-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


The Jean Coutu Group (PJC)  (OTCPK:JCOUF) 1-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


The Jean Coutu Group (PJC) 1-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of The Jean Coutu Group (PJC)'s 1-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


The Jean Coutu Group (PJC) (The Jean Coutu Group (PJC)) Business Description

Traded in Other Exchanges
N/A
Address
The Jean Coutu Group is a Canadian pharmaceutical retailer that operates under a franchise model. The company reports three segments: franchising, generic medicines, and intersegment sales. The company's stores sell branded and generic medication, over-the-counter medicine, health and beauty aids, perfumes, discount cosmetic lines, photography services, household items, pet supplies, groceries, and personal-care products. The bulk of Jean Coutu's revenue comes from prescription drug sales.

The Jean Coutu Group (PJC) (The Jean Coutu Group (PJC)) Headlines

From GuruFocus

The Jean Coutu Group – Dividend Fourth Quarter of Fiscal Year 2018

By GlobeNewswire GlobeNewswire 04-01-2018